Peripheral blood stem cell mobilisation by granulocyte-colony stimulating factor in patients with acute and old myocardial infarction for intracoronary cell infusion

Chang, S.-A.; Kang, H.-J.; Lee, H.-Y.; Kim, K.-H.; Hur, J.; Han, K.-S.; Park, Y.-B.; Kim, H.-S.
August 2009
Heart;Aug2009, Vol. 95 Issue 16, p13
Academic Journal
Background/aims: Peripheral blood stem cells (PBSC) are one of the most promising stem cell sources for treatment of ischaemic heart disease. However, the experience of mobilisation and collection of PBSC using granulocyte-colony stimulating factor (G-CSF) in patients with myocardial infarction (MI) is still limited. We report our experiences with the feasibility and safety of collection of mobilised PBSC with G-CSF in MI patients, and the influence of acute ischaemia on efficacy of PBSC collection. Methods: 74 patients with acute or old myocardial infarction (AMI vs OMI, n = 46 and n = 28) underwent PBSC collection after administration of G-CSF twice a day at a dose of 5 μg/kg for 3 days. Flow cytometric analysis of cell surface markers was performed. Results: No evidence of inflammation or ischaemia was observed during G-CSF mobilisation and PBSC collection. The yield of CD34+ cells was 12.9 (SD 15.92) ×109/l (5.04% (5.30%) of total cells) with a product volume of 37.9 (8.4) ml after 5650 (987) ml of blood were processed during PBSC collection. Stem cell mobilisation and collection by G-CSF is more efficient in AMI than in OMI, and proportions of cells positive for VE-cadherin or KDR/CD34 are significantly greater in AMI than in OMI (p<0.01). Conclusion: We could obtain sufficient numbers of PBSC for intracoronary infusion with the G-CSF-based mobilisation strategy without complications even in patients with MI. PBSC collection after mobilisation with G-CSF is a safe and feasible method of stem cell collection for therapeutic purpose in patients with MI.


Related Articles


    An abstract of the article "Improvement in Door-To-Balloon Times in Patients With ST-Elevation Myocardial Infarction in Beijing Anzhen Hospital" by Song Li, and Yan Hongbing is presented.

  • Comparison of Fondaparinux and Enoxaparin in Acute Coronary Syndromes.  // New England Journal of Medicine;4/6/2006, Vol. 354 Issue 14, p1464 

    Background: The combined use of anticoagulants, antiplatelet agents, and invasive coronary procedures reduces ischemic coronary events but also increases bleeding in patients with acute coronary syndromes. We therefore assessed whether fondaparinux would preserve the anti-ischemic benefits of...

  • Clinical digest. Stem cell therapies may reduce mortality in heart disease patients.  // Nursing Standard;5/14/2014, Vol. 28 Issue 37, p17 

    The article discusses research reported in the article "Stem Cell Therapy for Chronic Ischaemic Heart Disease and Congestive Heart Failure" by S. Fisher et al. in a 2014 issue of the "Cochrane Database of Systematic Reviews" which found that stem cell therapies may reduce mortality in heart...

  • Cell Therapy for the Treatment of Chronic Ischemic Heart Disease. Rodrigo, Sander F.; van Ramshorst, Jan; Beeres, Saskia L.M.A.; Bax, Jeroen J.; Schalij, Martin J.; Atsma, Douwe E. // Current Pharmaceutical Design;10/11/2011, Vol. 17 Issue 30, p3308 

    Over the last decade, much was learned about the biology of several types of stem and progenitor cells. It has become apparent that various cell sources may have the capacity to promote cardiomyogenesis and new blood vessel formation through different mechanisms, forming the rationale for...

  • Ritmos circadiano, circaseptano y circanual en el infarto agudo del miocardio. Ferrer Castro, Jacno E.; Corujo, Lianne Oliva; Ocejo, Marlene Fong; Castillo, Alejandro Rosell // MEDISAN;2013, Vol. 17 Issue 10, p1 

    A descriptive and cross-sectional study of 64 patients with acute myocardial infarction, assisted in "Dr. Joaquín Castillo Duany" Teaching Clinical Surgical Hospital in Santiago de Cuba was carried out during 2008, in order to determine the variability during cardiovascular events, with...

  • Persistent Inflammatory Pathways Associated with Early Onset Myocardial Infarction in a Medicated Multiethnic Hawaiian Cohort. Szauter, Kornelia M.; Jansen, Matthias K.; Okimoto, Gordon; Loomis, Michael; Kimura, James H.; Heller, Matthew; Ku, Tercia; Tiirikainen, Maarit; Boyd, Charles D.; Csiszar, Katalin; Girton, Richard A. // Biochemistry Insights;2011, Issue 4, p13 

    In spite of current standard therapies to target the major pathomechanisms in myocardial infarction (MI), inflammatory gene expression patterns have been consistently revealed in MI patients. In a multiethnic cohort, we aimed to identify MI-associated pathomechanisms that may be unresponsive to...

  • Experts call upon MDs to embrace guidance for post-MI.  // Medical Device Daily;8/29/2009, p2 

    The article reports on a call from experts from the Primary Care Cardiovascular Society and Heart UK for primary care clinicians to adopt a new guidance designed to support optimal care and treatment of post-myocardial infarction (MI) patients. The guidance, which was published in the "British...

  • Home based versus centre based cardiac rehabilitation: Cochrane systematic review and meta-analysis.  // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;1/30/2010, Vol. 340 Issue 7740, p249 

    The article discusses a Cochrane systematic review and meta-analysis of the effectiveness of home based cardiac rehabilitation programmes and supervised centre based cardiac rehabilitation programs. The researchers considered previous knowledge on the subject, including the effectiveness of the...

  • Time to Take Myocardial Reperfusion Injury Seriously. Hausenloy, Derek J.; Yellon, Derek M. // New England Journal of Medicine;7/31/2008, Vol. 359 Issue 5, p518 

    The authors reflect on myocardial infarction and reperfusion which is used in its treatment. They suggest that reperfusion remains the most effective strategy for myocardial infarction but can result in injury to the patient. They argue that one treatment strategy that might reduce the size of...


Read the Article


Sign out of this library

Other Topics